Scientific Reports · 2016 · 40 citations · 29 references
Life SciencesCardiologyImmunologyImmunopathologyImmunoregulationInflammationAtrial FibrillationCytokine BiologyCytokine DysregulationCytokine SignalingInflammatory ProcessesInflammatory SignalingAtrial Fibrillation BiomarkersAtrial Fibrillation Risk AssessmentInterleukin-17 PathwayLogistic Regression AnalysisPropensity Score AdjustmentRiskTh17 Responses
We performed a matched case-control study using a propensity score matching, to assess the association of Th17-related cytokines, including interleukin (IL) 17A (IL-17A), IL-17F, IL-21, IL-22 and IL-6, along with interferon-γ (IFN-γ), IL-10, IL-9, and IL-4, with the risk of AF. A total of 336 patients with AF were matched 1:1 with patients without AF. Plasma levels of cytokines were measured using Luminex xMAP assays. The plasma levels of all examined cytokines were significantly higher in AF patients than controls (P < 0.05), and these cytokines were highly correlated with each other (P < 0.01). A multivariate conditional logistic regression analysis showed that elevated plasma levels of IL-17A, IL-17F, IL-21, IL-22, IFN-γ, IL-10, IL-9 and IL-6 were significantly associated with AF risk independently of potential confounders. There were no significant differences in plasma levels of examined cytokines between paroxysmal and chronic AF patients. IL-17A, IL-21, IL-10 and IL-6 levels were positively correlated with left atrial diameter; IL-17F level was negatively correlated with left ventricle ejection fraction among AF patients (P < 0.05). Elevated plasma levels of Th17-related cytokines were independently associated with increased an risk of AF; hence, Th17-related cytokines may be involved in the pathogenesis of AF.
29
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn, Estelle Bettelli, Wenda Gao et al. · Nature · 2007 · 1.8K citations
Guidelines for the management of atrial fibrillation
A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · EP Europace · 2010 · 1.7K citations · Full text
Inflammation as a Risk Factor for Atrial Fibrillation
Ronnier J. Aviles, David O. Martin, Carolyn Apperson-Hansen et al. · Circulation · 2003 · 1.4K citations
Generation of pathogenic TH17 cells in the absence of TGF-β signalling
Kamran Ghoreschi, Arian Laurence, Xiang‐Ping Yang et al. · Nature · 2010 · 1.4K citations